A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

Clinical trial NCT06139367 · UNKNOWN

Trial details

NCT number: NCT06139367
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Biliary Carcinoma

Start date: 2023-11-01
Primary completion: 2023-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.